Skip to main content

Table 1 In-hospital patient characteristics

From: Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study

  Intervention Control
n = 225 n = 215
Age in years, median (25th–75th percentile) 75 (67–82) 75 (67–80)
Female, n (%) 86 (38.2) 75 (34.9)
Smoking, n (%) 25 (11.1) 23 (10.7)
BMI, median (25th–75th percentile) 27.9 (24.7–31.0) 27.2 (24.6–30.2)
Diabetes mellitus, n (%) 139 (61.8) 128 (59.5)
Chronic kidney disease, n (%) 121 (53.8) 123 (57.2)
Prior disease, n (%)   
Coronary artery disease 52 (23.1) 57 (26.5)
Stroke/TIA 52 (23.1) 44 (20.5)
Peripheral artery disease 8 (3.6) 9 (4.2)
Qualifying event, n (%)   
Unstable angina 7 (3.1) 9 (4.2)
NSTEMI 82 (36.4) 70 (32.6)
STEMI 30 (13.3) 24 (11.2)
TIA 35 (15.6) 42 (19.5)
Ischemic stroke 68 (30.2) 66 (30.7)
Haemorrhagic stroke 3 (1.3) 4 (1.9)
Treatment at admission, n (%)  
Antihypertensive drug (≥1) 183 (81.3) 188 (87.4)
Lipid-lowering drug 92 (40.9) 113 (52.6)
Treatment at discharge, n (%)  
Antihypertensive drug (≥1) 211 (93.8) 199 (92.6)
Lipid-lowering drug 185 (82.2) 180 (83.7)
  1. n number of cases, BMI body mass index (calculated as weight in kilograms divided by the squared height in meters), TIA transient ischemic attack, NSTEMI non-ST elevation myocardial infarction, STEMI ST elevation myocardial infarction